Finding 366485 (2021-006)

Material Weakness Repeat Finding
Requirement
L
Questioned Costs
-
Year
2021
Accepted
2024-02-07

AI Summary

  • Core Issue: UHU has been late in submitting financial reports, violating 2 CFR §200.512.
  • Impacted Requirements: Reports must be submitted within 30 days of receiving the auditor's report or nine months after the audit period ends.
  • Recommended Follow-Up: UHU should implement controls to ensure timely submission of reports moving forward.

Finding Text

Finding 2021-006: Financial Reports Information on Federal Program: Assistance Listing Numbers 93.914 and 93.917 Criteria or Specific Requirement: 2 CFR §200.512 requires that the completed audit, data collection form, and reporting package must be submitted within the earlier of 30 calendar days after receipt of the auditor's report(s), or nine months after the end of the audit period. Condition: UHU has been behind on the audit process and submission of reports has been delayed. Context: Due to delays in prior year audits, UHU was unable to submit the required reports by the required deadline. Cause: UHU did not have controls in place to ensure timely submission of their reports. Additionally, the information used to compile the financial data during the period for reporting was not reconciled timely to ensure appropriate reporting of the actual activity. Effect or Potential Effect: UHU was not in compliance with this regulation. Questioned Costs: None noted. Identification as a Repeat Finding, if Applicable: Repeat of Finding 2020-008 Recommendation: We recommend that UHU ensure that these reports are submitted within the required time period.

Categories

Reporting

Other Findings in this Audit

  • 366445 2021-001
    Material Weakness Repeat
  • 366446 2021-002
    Material Weakness Repeat
  • 366447 2021-003
    Material Weakness Repeat
  • 366448 2021-004
    Material Weakness Repeat
  • 366449 2021-005
    Material Weakness Repeat
  • 366450 2021-006
    Material Weakness Repeat
  • 366451 2021-007
    Material Weakness Repeat
  • 366452 2021-001
    Material Weakness Repeat
  • 366453 2021-002
    Material Weakness Repeat
  • 366454 2021-003
    Material Weakness Repeat
  • 366455 2021-004
    Material Weakness Repeat
  • 366456 2021-005
    Material Weakness Repeat
  • 366457 2021-006
    Material Weakness Repeat
  • 366458 2021-007
    Material Weakness Repeat
  • 366459 2021-001
    Material Weakness Repeat
  • 366460 2021-002
    Material Weakness Repeat
  • 366461 2021-003
    Material Weakness Repeat
  • 366462 2021-004
    Material Weakness Repeat
  • 366463 2021-005
    Material Weakness Repeat
  • 366464 2021-006
    Material Weakness Repeat
  • 366465 2021-007
    Material Weakness Repeat
  • 366466 2021-001
    Material Weakness Repeat
  • 366467 2021-002
    Material Weakness Repeat
  • 366468 2021-003
    Material Weakness Repeat
  • 366469 2021-004
    Material Weakness Repeat
  • 366470 2021-005
    Material Weakness Repeat
  • 366471 2021-006
    Material Weakness Repeat
  • 366472 2021-007
    Material Weakness Repeat
  • 366473 2021-001
    Material Weakness Repeat
  • 366474 2021-002
    Material Weakness Repeat
  • 366475 2021-003
    Material Weakness Repeat
  • 366476 2021-004
    Material Weakness Repeat
  • 366477 2021-005
    Material Weakness Repeat
  • 366478 2021-006
    Material Weakness Repeat
  • 366479 2021-007
    Material Weakness Repeat
  • 366480 2021-001
    Material Weakness Repeat
  • 366481 2021-002
    Material Weakness Repeat
  • 366482 2021-003
    Material Weakness Repeat
  • 366483 2021-004
    Material Weakness Repeat
  • 366484 2021-005
    Material Weakness Repeat
  • 366486 2021-007
    Material Weakness Repeat
  • 942887 2021-001
    Material Weakness Repeat
  • 942888 2021-002
    Material Weakness Repeat
  • 942889 2021-003
    Material Weakness Repeat
  • 942890 2021-004
    Material Weakness Repeat
  • 942891 2021-005
    Material Weakness Repeat
  • 942892 2021-006
    Material Weakness Repeat
  • 942893 2021-007
    Material Weakness Repeat
  • 942894 2021-001
    Material Weakness Repeat
  • 942895 2021-002
    Material Weakness Repeat
  • 942896 2021-003
    Material Weakness Repeat
  • 942897 2021-004
    Material Weakness Repeat
  • 942898 2021-005
    Material Weakness Repeat
  • 942899 2021-006
    Material Weakness Repeat
  • 942900 2021-007
    Material Weakness Repeat
  • 942901 2021-001
    Material Weakness Repeat
  • 942902 2021-002
    Material Weakness Repeat
  • 942903 2021-003
    Material Weakness Repeat
  • 942904 2021-004
    Material Weakness Repeat
  • 942905 2021-005
    Material Weakness Repeat
  • 942906 2021-006
    Material Weakness Repeat
  • 942907 2021-007
    Material Weakness Repeat
  • 942908 2021-001
    Material Weakness Repeat
  • 942909 2021-002
    Material Weakness Repeat
  • 942910 2021-003
    Material Weakness Repeat
  • 942911 2021-004
    Material Weakness Repeat
  • 942912 2021-005
    Material Weakness Repeat
  • 942913 2021-006
    Material Weakness Repeat
  • 942914 2021-007
    Material Weakness Repeat
  • 942915 2021-001
    Material Weakness Repeat
  • 942916 2021-002
    Material Weakness Repeat
  • 942917 2021-003
    Material Weakness Repeat
  • 942918 2021-004
    Material Weakness Repeat
  • 942919 2021-005
    Material Weakness Repeat
  • 942920 2021-006
    Material Weakness Repeat
  • 942921 2021-007
    Material Weakness Repeat
  • 942922 2021-001
    Material Weakness Repeat
  • 942923 2021-002
    Material Weakness Repeat
  • 942924 2021-003
    Material Weakness Repeat
  • 942925 2021-004
    Material Weakness Repeat
  • 942926 2021-005
    Material Weakness Repeat
  • 942927 2021-006
    Material Weakness Repeat
  • 942928 2021-007
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.939 Hiv Prevention Activities_non-Governmental Organization Based $309,237
93.136 Injury Prevention and Control Research and State and Community Based Programs $207,309
93.917 Hiv Care Formula Grants $199,583
19.029 The U.s. President's Emergency Plan for Aids Relief Programs $150,000
93.940 Hiv Prevention Activities_health Department Based $59,756
93.279 Drug Abuse and Addiction Research Programs $38,859
93.914 Hiv Emergency Relief Project Grants $500